Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech SAN JOSE, Calif., May 17, 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce...
Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B
Bagsværd, Denmark, – Novo Nordisk today announced the completion of paradigm™ 2, the first phase 3 trial with a long-acting FIX derivative, N9-GP (glycopegylated recombinant factor...
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease
AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease First selective JAK1 inhibitor to enter Phase 2 studies in Crohn's disease Galapagos to fund and complete Phase 2...
Biologix Hair Inc. Appoints Dr. Michael Stocker Director and CEO; J. Gregory Wilson Appointed CFO
Biologix Hair Inc. Appoints Dr. Michael Stocker Director and CEO; J. Gregory Wilson Appointed CFO 5/15/2013 10:46:58 AM Staying up-to-date has never been simpler. Sign up for the free GenePool...
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team
Achillion Appoints Dr. David Apelian as Chief Medical Officer and Expands Clinical Operations Team 0 0 0 17 May 15, 2013 06:00 | Source: Achillion Pharmaceuticals, Inc. NEW HAVEN, Conn., May 15,...
Harvard Bioscience Inc. (HBIO) Announces Retirement of CEO and Appointment of Interim CEO
Harvard Bioscience Inc. (HBIO) Announces Retirement of CEO and Appointment of Interim CEO Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Harvard...
BioTime Appoints Franklin Berger to Board of Directors
BioTime Appoints Franklin Berger to Board of Directors ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE MKT: BTX) today announced that Franklin M. Berger, CFA, 63, has been appointed to its...
Bay City Capital Expands Team With the Addition of David Beier, JD
Bay City Capital Expands Team With the Addition of David Beier, JD SAN FRANCISCO--(BUSINESS WIRE)--Bay City Capital, a leading venture capital firm focused on early-stage to growth equity investments...
VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors
VIVUS Appoints J. Martin Carroll and Jorge Plutzky, M.D. to Board of Directors May 13, 2013 07:00 | Source: VIVUS, Inc. MOUNTAIN VIEW, Calif., May 13, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc....
Valeant Pharmaceuticals International (VRX) Announces Resignation of Dr. Laurence Paul from Valeant's Board of Directors
LAVAL, Quebec, May 15, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced that Dr.Laurence Paul has resigned from Valeant's Board of Directors due...
Immunotec's Mr. Robert M. Henry Departs as CEO
Immunotec's Mr. Robert M. Henry Departs as CEO Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Immunotec Announces CEO Departure VAUDREUIL-DORION,...
Safety results from Auris Medical's clinical development of AM-101 presented at international conference
May 17, 2013 – Safety results from Auris Medical's clinical development of AM-101 presented at international conference Key safety outcomes from Auris Medical's clinical development of...
Rib-X Pharmaceuticals Appoints John E. Sununu to the Board of Directors
Rib-X Pharmaceuticals Appoints John E. Sununu to the Board of Directors NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc. today announced the appointment of former U.S. Senator John E....
Sanford-Burnham Medical Research Institute Recruits Genomics Expert Laszlo Nagy, M.D., Ph.D., to Head New Multidisciplinary Research Program
ORLANDO, Fla., May 14, 2013 – Sanford-Burnham Medical Research Institute at Lake Nona (Sanford-Burnham) announced the recruitment of the internationally renowned genomic scientist...
Hospira, Inc. (HSP) Reappoints Dr. Sumant Ramachandra Chief Scientific Officer
LAKE FOREST, Ill., May 14, 2013 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that Sumant Ramachandra,...
Zosano Pharma, Inc. Appoints Nandan Oza as Chief Operations Officer
REMONT, Calif., May 14, 2013 /PRNewswire/ -- Zosano Pharma, Inc., a privately held pharmaceutical company developing products based on its novel transdermal delivery technology, announced today a key...
Optimer Pharmaceuticals, Inc. (OPTR) Appoints Eric Sirota as Chief Operating Officer
JERSEY CITY, N.J., May 13, 2013 /PRNewswire/ -- Optimer Pharmaceuticals (NASDAQ: OPTR) (the "Company" or "Optimer") today announced the appointment of Mr. Eric Sirota as Chief...
Alkermes Elects Nancy Wysenski to Board of Directors
DUBLIN--(BUSINESS WIRE)--Alkermes plc (NASDAQ: ALKS) today announced the election of Nancy J. Wysenski to the company's Board of Directors. Most recently serving as Chief Commercial Officer at...
Jack Green Joins Verastem as Chief Financial Officer
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Verastem, Inc., (NASDAQ: VSTM) focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the appointment...
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis Paris, France - May 17, 2013- Sanofi (EURONEXT: SAN and NYSE: SNY) announced today...
